Online Database of Chemicals from Around the World
| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 147254-64-6 | Ranirestat | C17H11BrFN3O4 |
| 147255-70-7 | (S)-2-Pyrrolidineboronic acid (-)-pinanediol ester hydrochloride | C14H24BNO2.HCl |
| 147266-92-0 | N-Boc-trans-4-hydroxy-D-proline | C10H17NO5 |
| 147269-67-8 | Benzyl 2-oxo-1,2-dihydropyridin-3-ylcarbamate | C13H12N2O3 |
| 147290-10-6 | N5-[(2-Propen-1-yloxy)carbonyl]-L-ornithine | C9H16N2O4 |
| 147290-11-7 | N2-Fmoc-N5-allyloxycarbonyl-L-ornithine | C24H26N2O6 |
| 147291-66-5 | tert-Butyl 3-aminobenzylcarbamate | C12H18N2O2 |
| 147299-15-8 | 1-(1-Benzo[b]thien-2-ylcyclohexyl)pyrrolidine | C18H23NS |
| 147311-08-8 | 4-(3-Pyridinyl)-2-thiazolamine hydrobromide | C8H7N3S.HBr |
| 147315-50-2 | 2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-[(hexyl)oxy]-phenol | C27H27N3O2 |
| 147317-15-5 | Antibiotic PF 1052 | C26H39NO4 |
| 147325-09-5 | N-[(1,1-Dimethylethoxy)carbonyl]-L-homoserine ethyl ester | C11H21NO5 |
| 147331-98-4 | Plantainoside D | C29H36O16 |
| 147359-76-0 | Flibanserin hydrochloride | C20H21F3N4O.HCl |
| 147372-41-6 | 2-Chloro-N-(4-methylphenyl)propanamide | C10H12ClNO |
| 147372-85-8 | 3,4-Dihydrospiro[chromene-2,4'-piperidine] | C13H17NO |
| 147395-39-9 | (S)-N-Acetyl-L-tyrosyl-L-valyl-N-[1-(dimethoxymethyl)-3-(1,1-dimethylethoxy)-3-oxopropyl]-L-alaninamide | C29H46N4O9 |
| 147396-01-8 | Ligupurpuroside A | C35H46O19 |
| 147396-02-9 | Ligupurpuroside B | C35H46O17 |
| 147403-03-0 | Azilsartan | C25H20N4O5 |
| 147403-52-9 | 1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester | C26H22N4O5 |
| 147403-65-4 | 2-Ethoxy-1-[[2'-[(hydroxyamino)iminomethyl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid methyl ester | C25H24N4O4 |
| 147404-72-6 | 4'-(Bromomethyl)biphenyl-2-carboxamide | C14H12BrNO |
| 147404-75-9 | Azilsartan impurity F | C22H21N3O3 |
| 147404-76-0 | Azilsartan impurity A | C25H23N3O4 |
| 147404-82-8 | 2-Ethoxy-1-[[2'-[[[(ethoxycarbonyl)oxy]amino]iminomethyl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid methyl ester | C28H28N4O6 |
| 147419-93-0 | Ginsenoside Rg6 | C42H70O12 |
| 147438-27-5 | Seco Rapamycin | C51H79NO13 |
| 147438-30-0 | (2S)-1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-Dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrien-1-yl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]-2-oxoacetyl]-2-piperidinecarboxylic acid | C32H49NO9 |
| 147444-03-9 | Pyripyropene A | C31H37NO10 |
| 147459-51-6 | cis-Octahydropyrrolo[3,4-b]pyridine | C7H14N2 |
| 147459-52-7 | N -(3-Methyl-3-pyrrolidinyl)-carbamic acid 1,1-dimethylethyl ester | C10H20N2O2 |
| 147460-41-1 | 2-Bromo-5-fluorophenol | C6H4BrFO |
| 147489-06-3 | (4R,6S)-6-[(1E)-2-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid tert-butyl ester | C32H36FNO4 |
| 147497-32-3 | 6-Bromo-3,4-dihydro-2H-isoquinolin-1-one | C9H8BrNO |
| 147497-41-4 | 6-Bromo-2-(phenylmethyl)-1(2H)-isoquinolinone | C16H12BrNO |
| 147511-69-1 | Pitavastatin | C25H24FNO4 |
| 147511-70-4 | (3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid (+)-phenylethylamine salt | C25H24FNO4.C8H11N |
| 147517-06-4 | 3,4-Dihydro-6,8-dihydroxy-3-(4-hydroxyphenyl)-1H-2-benzopyran-1-one | C15H12O5 |
| 147526-32-7 | Pitavastatin calcium | (C25H23FNO4)2.Ca |
| 147528-20-9 | 2-Propenyl-2-propynylcarbamic acid tert-butyl ester | C11H17NO2 |
| 147529-99-5 | 6-N-Allyloxycarbonyl-L-lysine hydrochloride | C10H18N2O4.HCl |
| 147531-11-1 | Diphenyl(trifluoromethyl)sulfonium trifluoromethanesulfonate | C14H10F6O3S2 |
| 147536-97-8 | Bosentan | C27H29N5O6S |
| 147539-29-5 | 1-(3-Nitropyridin-2-yl)-1,4-diazepane | C10H14N4O2 |
| 147539-41-1 | 1-Boc-4-Methylaminopiperidine | C11H22N2O2 |
| 147568-66-9 | Carmoterol | C21H24N2O4 |
| 147591-46-6 | 1-(4-Methoxyphenyl)-2-methyl-3-nitro-1H-indol-6-ol | C16H14N2O4 |
| 147591-52-4 | 1-(1H-Indol-5-yl)ethanamine | C10H12N2 |
| 147600-40-6 | Acetyl-L-leucyl-L-valyl-L-lysinal | C19H36N4O4 |